Related by context. All words. (Click for frequent words.) 69 prostate carcinogenesis 69 antioxidant supplementation 67 selenium supplementation 67 developmental neurotoxicity 67 underlying pathophysiology 66 mechanistic explanation 66 riociguat 66 creatine supplementation 66 adrenal function 66 biological plausibility 66 prognostic indicators 65 neurotrophic 65 antiplatelet therapies 65 EBV infection 65 testosterone supplementation 65 BCL#A 65 carotid plaque 65 probiotic supplementation 65 dietary interventions 65 estrogen metabolism 65 etiologic 65 unmeasured confounding 65 dietary antioxidants 64 familial clustering 64 chemosensitivity 64 residual confounding 64 unmeasured confounders 64 pituitary hormone 64 Genetic predisposition 64 periodontal infection 64 atherosclerosis regression 64 antitumor effect 64 LRP5 64 beta carotene supplementation 64 platelet activation 64 prognostically 64 trans palmitoleate 64 growth hormone secretion 63 physiologic mechanisms 63 PPARγ 63 intestinal permeability 63 receptor inhibitor 63 anti androgens 63 prostate cancer CaP 63 phenotypic expression 63 Akt activation 63 chemopreventive agent 63 cardiac fibrosis 63 elevated homocysteine 63 adrenal suppression 63 etiological 63 DHEA supplementation 63 thyrotropin 63 cardioprotective effects 63 immunoregulatory 63 antitumor efficacy 63 ovarian hormones 63 immunopathology 63 antiproliferative effects 63 dietary acrylamide 63 familial predisposition 62 remyelination 62 cranial irradiation 62 KRAS variant 62 clinicopathological 62 CYP #A# 62 pharmacologic interventions 62 FUS protein 62 pharmacologic intervention 62 prognostic significance 62 tumorigenicity 62 antiangiogenic therapy 62 sirtuin activators 62 nonpharmacologic 62 mTOR inhibition 62 chronic periodontitis 62 colorectal carcinogenesis 62 flavopiridol 62 arterial calcification 62 cardiovascular morbidity 62 erythropoietic 62 KRAS mutation status 62 Lymph node 62 CaPre TM 62 immunomodulatory effects 62 Hedgehog inhibitor 62 AST ALT 62 PKCi 62 prognostic marker 62 fibrotic disease 62 atherogenesis 62 elevated CRP 62 chromium supplementation 62 plasma lipoprotein 62 telomerase activation 62 ConclusionThis 62 favorable pharmacokinetic profile 62 mitochondrial toxicity 62 chlamydial 62 glycolytic 62 TMPRSS2 ERG fusion 62 causal inference 62 genotype phenotype 62 PPAR γ 62 gut microbiota 62 HIV HCV coinfected 62 metaanalysis 62 Rigorous scientific 62 Cognitive impairment 62 anti angiogenic agents 62 mTOR inhibitors 62 stratifying patients 62 pharmacological therapies 62 thromboembolic disease 62 FGFs 62 pharmacogenetic testing 62 synovial cells 62 plasma lipid 62 nonalcoholic steatohepatitis NASH 62 generalisability 61 perioperative morbidity 61 immunomodulation 61 Nod1 61 poststroke depression 61 CB2 receptor 61 metastatic lymph nodes 61 pyridostigmine 61 Helicobacter pylori infection 61 renal fibrosis 61 thyroid dysfunction 61 triglyceride lowering 61 KRAS mutation 61 Zevalin consolidation 61 postmenopausal estrogen 61 lipid lowering therapies 61 E. faecalis 61 pleiotropic 61 HER2 overexpression 61 intestinal motility 61 antitumour 61 proteoglycan 61 Kaplan Meier curve 61 gastric carcinoma 61 menadione 61 aetiological 61 activin 61 colorectal adenoma 61 epithelial tumors 61 myocyte 61 selenium intake 61 DNA methylation patterns 61 Genetic variation 61 impair fertility 61 prostaglandin synthesis 61 neuroinflammatory 61 non pharmacological interventions 61 urothelial cancer 61 HSF1 61 motor neuron degeneration 61 intestinal microflora 61 haematopoietic 61 dyslipidaemia 61 hepatic fibrosis 61 periodontal infections 61 magnesium supplementation 61 ADAMTS# 61 K ras mutations 61 hepatotoxic 61 cardiac biomarkers 61 mechanistic studies 61 anticancer activity 61 angiogenesis inhibition 61 Virulizin ® 61 stimulate neurogenesis 61 diabetic kidney 61 folate supplementation 61 EGFR mutation status 61 pleiotropic effects 61 CETP inhibition 61 biochemical abnormalities 61 XMRV infection 61 antimetastatic 61 hepatic toxicity 61 PARP inhibition 61 imatinib resistance 61 mutated K ras 61 serum vitamin D 61 UCP2 61 prognostic indicator 61 histopathological 61 β blockers 61 chlamydial infection 61 APOE genotype 61 pathophysiologic 61 HMGCR 61 Lipoic acid 61 amyloid cascade 61 neuroregenerative 61 Vitamin D supplementation 61 androgen deficiency 60 gastric adenocarcinoma 60 thiopurine 60 pathophysiological mechanisms 60 amyloid hypothesis 60 spermidine 60 immunosuppressive therapies 60 artifactual 60 adiponectin levels 60 LC#m# vaccine 60 renoprotective 60 amyloid plaque formation 60 cardioprotection 60 non selective NSAIDs 60 pathophysiologic mechanisms 60 Prognostic factors 60 soluble CD# 60 TGF ß 60 antioxidant intake 60 oral Xeloda 60 mucinous 60 GSTM1 gene 60 systemic inflammation 60 incidentalomas 60 pharmacological interventions 60 myeloproliferative diseases 60 mitochondrial mutations 60 statins cholesterol lowering 60 serum BDNF 60 lung cancer chemoprevention 60 fusion enhancers 60 Adjuvant chemotherapy 60 fatty acid oxidation 60 differential gene expression 60 Multiple logistic regression 60 Dr. Bezprozvanny 60 vitamin D inadequacy 60 tumor subtypes 60 immune modulating 60 liver metastasis 60 pathophysiological 60 homocysteine concentrations 60 BEXXAR Therapeutic Regimen 60 dyslipidemias 60 oxysterols 60 OGG1 60 intravenous bisphosphonates 60 plasminogen activators 60 resolvins 60 plasma pharmacokinetics 60 Candida infection 60 pentoxifylline 60 IV bisphosphonates 60 breast endometrial 60 generalizability 60 cardioprotective effect 60 immunological responses 60 ergogenic 60 scintigraphic 60 Th2 immune 60 endogenous estrogen 60 chemoprotective 60 molecular determinants 60 myocardial dysfunction 60 folate deficiency 60 hematopoietic cancers 60 ABCB1 60 antibody mediated 60 SNP rs# [002] 60 Treg cell 60 intracerebral haemorrhage 60 PNH patients 60 PTHrP 60 H. pylori infection 60 WNK1 60 indibulin 60 antidepressant efficacy 60 neurite outgrowth 60 nutrient supplementation 60 mGlu2 3 60 gastrointestinal absorption 60 H. pylori eradication 60 estrogenic effects 60 tumor histology 60 genetic polymorphisms 60 colorectal tumor 60 #ME# 60 NAbs 60 PITX2 methylation 60 subclinical atherosclerosis 60 bowel polyps 60 organophosphate exposure 60 methodologically rigorous 60 CYP #D# 60 genetic loci 60 PI3K signaling 60 serum parathyroid hormone 60 paricalcitol 60 oral JAK1 60 clinico pathological 60 p# activation 60 aromatase inhibitors AIs 60 fluoroquinolone resistance 60 vascular dysfunction 60 Calcium intake 60 etiologic factors 60 atherosclerotic vascular disease 60 oxidized lipids 60 neurohormonal 60 aberrant activation 60 biologic pathways 60 antiangiogenic agent 60 lung epithelium 60 VEGF expression 60 IGF IR 60 cellularity 60 pulmonary toxicity 60 biphosphonates 60 antitumoral 60 intensive statin therapy 60 ERK signaling 60 Subgroup analyzes 60 pro angiogenic 60 bone metabolism 60 Li Fraumeni 60 spontaneous regression 60 inecalcitol 60 tryptase 60 isoflavone supplement 60 AA Amyloidosis 60 antitumour activity 60 Helicobacter infection 60 thyrotropin levels 60 sonographic diagnosis 60 oncogenesis 60 curative therapy 59 Magnesium deficiency 59 infantile colic 59 mammary cancers 59 glial tumors 59 ventricular remodeling 59 pharmacological intervention 59 atherothrombotic 59 tumor subtype 59 PCNSL 59 neuropsychological impairments 59 lymphoid tumors 59 microglial 59 SSc 59 TGFß 59 serologic 59 aerodigestive tract 59 Symadex 59 suppressor gene 59 potentially modifiable 59 intercellular signaling 59 antioxidant vitamin supplements 59 mechanistic insights 59 endometrial hyperplasia 59 Mechanistic studies 59 T1DM 59 ADRB2 59 tumoral 59 hormesis 59 hereditary predisposition 59 Cochrane reviewers 59 survivin expression 59 neovascular 59 serum biomarkers 59 Fc receptor 59 IL6 59 Aldosterone 59 hormone aldosterone 59 gastro oesophageal reflux 59 malignant transformation 59 osteoblast 59 STAT4 59 SIADH 59 ALI ARDS 59 periodontal tissues 59 tramiprosate 59 neuronal plasticity 59 histone acetylation 59 AGHD 59 DNA demethylation 59 neuropathologic 59 convergent validity 59 endothelial activation 59 B7 H4 59 mucosal immunity 59 adenosine receptors 59 natriuretic peptides 59 cytoprotective 59 antiphospholipid antibodies 59 Sjögren syndrome 59 mechanistic insight 59 metabolic abnormality 59 NSAID induced GI 59 periodontal bacteria 59 lung fibroblasts 59 metabolic dysfunction 59 pathogenic mechanisms 59 Meta analyzes 59 hypothalamic pituitary adrenal axis 59 metastatic uveal melanoma 59 cardiac glycosides 59 squamous cell lung cancer 59 ovarian suppression 59 untreated celiac disease 59 hyperplastic polyps 59 synovial tissue 59 lymphomas leukemias 59 chitinase 59 papillary renal cell carcinoma 59 androgen hormone 59 pressure natriuresis 59 serum PTH 59 kidney urologic 59 chemoprevention trials 59 Genetic variations 59 IGFBP 3 59 hemodilution 59 prostate carcinoma 59 cardiovascular disease hypertension 59 plasma kallikrein 59 correlational 59 noncancer 59 dosing frequency 59 oral anticoagulation 59 antiangiogenic 59 metabolomic profiles 59 neurosensory 59 KLF4 59 psychobiological 59 ACAT2 59 JAK inhibitors 59 chemopreventive agents 59 adjuvant therapies 59 cardiolipin 59 beta1 integrin 59 dose proportionality 59 VADT 59 oncological outcomes 59 rBChE 59 serum lipid levels 59 PEDF 59 molecular abnormalities 59 ALB # 59 inhibit metastasis 59 primary aldosteronism 59 breast cancer subtypes 59 conjugated estrogen 59 molecular biomarkers 59 myeloperoxidase 59 ziconotide 59 Soy isoflavones 59 Chlamydia pneumoniae 59 CYP#D# genotype 59 biologically plausible 59 #F FDG PET 59 Myerburg 59 histological subtype 59 serum retinol 59 tHcy 59 surrogate markers 59 redox active 59 ursodeoxycholic acid 59 carotid IMT 59 myocardial ischemia 59 proinflammatory cytokine 59 pharmacologic approaches 59 Parkinson disease neurodegenerative disorder 59 subclinical hypothyroidism 59 prothrombotic 59 psychiatric comorbidity 59 statin medications 59 G6PD deficiency 59 intestinal mucosal 59 lymphocyte activation 59 Heavy menstrual bleeding 59 prion infection 59 Selenium supplements 59 oesophageal adenocarcinoma 59 herpes zoster vaccine 59 radiographic findings 59 allergic airway inflammation 59 intracranial stenosis 59 murine models 59 fetal microchimerism 59 Squalamine 59 OHR/AVR# 59 postoperative AF 59 prognostic markers 59 NKG2D 59 skeletal metastases 59 prostate cancer PCa 59 antiresorptive 59 PECAM 1 59 intestinal microbiota 59 airway hyperresponsiveness 59 lipoic acid 59 Lung transplantation 59 endotoxemia 59 sCD# 59 trastuzumab Herceptin ® 59 fibrate drugs 59 intestinal mucosa 59 atherogenic 59 PTH secretion 59 radioimmunotherapy RIT 59 p# mutations 59 neurodevelopmental outcome 59 autoregulation 59 neuropathological 58 hyperoxaluria 58 metabonomics 58 DACH platinum 58 LVNC 58 endogenous hormones 58 pathogenetic mechanisms 58 LDL lowering 58 phytoestrogen intake 58 environmental toxicants 58 platelet function 58 TNFa 58 anti leukemic 58 Iron deficiency anemia 58 Alpha lipoic acid 58 systemic toxicity 58 coronary calcification 58 delayed gastric emptying 58 haematologic 58 MAPK pathway 58 eosinophil count 58 methodologic 58 EGFR signaling 58 neuronal signaling 58 darbepoetin alpha 58 mGluR5 inhibition 58 atherosclerotic disease 58 transgenic rats 58 dopamine neuron 58 Okunieff 58 pleiotropy 58 Adequate vitamin D 58 L lysine 58 serum IgE 58 surrogate marker 58 ACCORD Lipid 58 HER2 expression 58 airway responsiveness 58 Xanafide 58 PITX2 58 KRAS status 58 psoriatic 58 epithelial barrier 58 p#NTR 58 glucocorticoid hormones 58 Oligonol 58 C. pneumoniae 58 Aplidin 58 thrombotic complications 58 dietary nitrate 58 inflammatory bowel syndrome 58 ascertainment bias 58 vitamin B# supplements 58 chromosomal instability 58 NAT2 58 NKX#.# 58 SCD1 58 axillary node 58 osteoarthritic 58 Pseudomonas aeruginosa infections 58 signaling cascades 58 TGFBR1 * 6A 58 H pylori 58 methodological rigor 58 antihypertensive therapy 58 miglustat 58 autistic enterocolitis 58 hawthorn extract 58 CEACAM1 58 gastric carcinogenesis 58 pressor response 58 serum antibodies 58 pre malignant lesions 58 mitochondrial metabolism 58 carotid atherosclerosis 58 nongenetic 58 matriptase 58 SERMs 58 S. maltophilia 58 conventional angiography 58 COX enzymes 58 anti fibrotic 58 transgene expression 58 Dietary restriction 58 vasodilatation 58 sGC 58 folate intake 58 serotonin synthesis 58 GPx 58 KIF6 gene variant 58 bronchoalveolar 58 interstitial lung abnormalities 58 myopathies 58 membranous nephropathy 58 lipid lowering therapy 58 cardiac myocytes 58 calcium homeostasis 58 stone formers 58 inotropic 58 Genetic variants 58 mixed hyperlipidemia 58 lymphoproliferative disorder 58 intracellular bacteria 58 Chronic pancreatitis 58 biopsychosocial 58 cardiac troponin 58 fructose intake 58 benfotiamine 58 Non inferiority 58 FDG PET imaging 58 anatomic abnormalities 58 cAMP signaling 58 cAMP pathway 58 heparanase 58 chemopreventive 58 p# MAPK 58 coexpression 58 EGFR expression 58 Inhaled nitric oxide 58 inhaled nitric oxide 58 EGFR antibodies 58 therapeutic regimens 58 autonomic dysfunction 58 CaPre ™ 58 nucleosome positioning 58 enzymatic pathways 58 plasma renin activity 58 R roscovitine 58 clioquinol 58 dietary folate 58 neurofibrillary 58 glutamate signaling 58 late onset hypogonadism 58 antioxidant supplements 58 rhIGF 58 serum GGT 58 eculizumab therapy 58 Hotamisligil 58 small molecule activators 58 magnesium intake 58 STAT3 signaling 58 arachidonic acid AA 58 arterial inflammation 58 pathogenetic 58 cisplatin resistant 58 underlying molecular mechanisms 58 pramlintide metreleptin combination 58 axonal degeneration 58 immune modulator 58 epidemiologic studies 58 histologic diagnosis 58 vitamin D calcium 58 atherosclerotic lesions 58 PLX cells 58 prophylactic cranial irradiation 58 vitamin supplementation 58 intact parathyroid hormone 58 bile acid metabolism 58 LHRH agonists 58 serum calcium 58 DFMO 58 effector function 58 type 1diabetes 58 acetabular dysplasia 58 eNOS 58 neurocognitive function 58 canakinumab 58 unmeasured factors 58 TRAIL induced apoptosis 58 adult neurogenesis 58 metabolic disturbances 58 MIF protein 58 cardio protective 58 CagA 58 erlotinib Tarceva 58 peroxynitrite 58 CYP#C# gene 58 vascularisation 58 immunological mechanisms 58 NO synthase 58 oral anticoagulant therapy 58 esophageal reflux 58 extramedullary 58 PON1 gene 58 IKK2 58 SE alleles 58 predisposing factor 58 PB1 F2 58 genotoxicity 58 endoxifen 58 pancreatic adenocarcinoma 58 metabolizing enzymes 58 nitrite nitrate 58 estrone 58 coagulation abnormalities 58 intensive lipid lowering 58 dexrazoxane 58 gastric cardia 58 G. biloba 58 gene polymorphisms 58 carcinoids 58 pharmacodynamic parameters 58 antioxidant nutrients 58 florbetaben 58 bony metastases 58 strontium ranelate 58 intermittent hypoxia 58 thrombogenic 58 posttranslational modification 58 noninfectious uveitis 58 COX2 58 Statin therapy 58 pharmacodynamic PD 58 TNF α 58 clinically insignificant 58 subgroup analyzes 58 ganaxolone 58 Caloric restriction 58 confounder 58 oncomodulin 58 proteasome inhibition 58 fluoride ingestion 58 HbF 58 hyperalgesia 58 vertebral subluxation 58 N Myc 58 antiapoptotic 58 serum uric acid 58 lipoprotein metabolism 58 polyp detection 58 MMP inhibitors 58 serum urate levels 58 kallikrein 58 eotaxin 58 endocrinologic 58 CaM kinase II 58 DHA supplementation 58 IRAK1 58 genetic polymorphism 58 deacetylase inhibitors 58 knee osteoarthritis OA 58 modifiable lifestyle 58 act synergistically 58 Th2 responses 58 microbiomes 58 androgen signaling 58 anti atherogenic 58 mGluR5 antagonist 58 Ashwell receptor 58 colon carcinogenesis 58 Cyclin E 58 MTHFR 58 cardiac repolarization 58 p#/CBP 58 cancerdefine 58 nephrotoxicity 58 mucosal immune 58 non ulcer dyspepsia 58 imexon 58 neurosteroid 58 glucose homeostasis 58 antithrombotic therapy 58 ApoA1 58 microRNA expression 58 perfusion abnormalities 58 endophenotypes 58 mGluR4 activation 58 Randomized clinical trials 58 histone deacetylase HDAC 58 vidofludimus 58 apolipoproteins 58 hyperhomocysteinemia 58 effector functions 58 androgen deprivation 58 humoral immunity 58 calcium excretion 58 XmAb# 58 dietary carbohydrate 57 antitumor effects 57 subcellular compartments 57 nonalcoholic steatohepatitis 57 alpha7 NNR 57 adipocyte 57 osteogenic 57 Skeletal muscle 57 genomewide 57 CYT# potent vascular disrupting 57 NNRTI resistance 57 gallstone disease 57 HIF PH inhibitors 57 commensal bacteria 57 ZNF# 57 C1q 57 preclinically 57 telomere dysfunction 57 serum leptin 57 antiangiogenic agents 57 genomewide association studies 57 COMMD1 57 RIP1 57 aldosterone hormone 57 androgen therapy 57 HDAC6 57 anti androgen 57 periprocedural MI 57 synaptic function 57 de novo mutations 57 miRs 57 BMPR2 57 locoregional recurrence 57 beta lactam antibiotic 57 paraneoplastic 57 presymptomatic 57 impaired insulin secretion 57 Smac mimetic 57 prognostic biomarker 57 clinically meaningful 57 RE LY trial 57 anti angiogenic drugs 57 chromosomal aberrations 57 Chlamydia psittaci 57 pharmacokinetic characteristics 57 alteplase 57 mitochondrial disorders 57 neuroactive 57 M.tb 57 PM#.# exposure 57 IntroductionThe 57 IL #E 57 ADME properties 57 MUC1 * 57 selective inhibition 57 equol 57 lowering triglycerides 57 inverse agonist 57 adipocyte differentiation 57 CXCR7 57 immuno suppressive 57 Buhimschi 57 erythropoiesis 57 metabolic alterations 57 LHRH receptor positive 57 dentin hypersensitivity 57 cerebral ischemia 57 acadesine 57 pharmacokinetic interactions 57 apneic episodes 57 elevated triglyceride levels 57 hippocampal function 57 neuropsychiatric symptoms 57 IFRD1 57 clinicopathologic 57 immunosuppressive regimens 57 CYP#A# enzyme 57 TNF antagonist 57 physico chemical properties 57 hyperparathyroidism 57 platelet inhibition 57 postmenopausal hormones 57 genotoxic stress 57 silibinin 57 Bcl xL 57 HER2 neu 57 IL 1ß 57 enzyme inhibitors 57 potency selectivity 57 neuronal dysfunction 57 preterm neonates 57 heritable variation 57 allogeneic HSCT 57 lesional 57 Helicobacter 57 microglial activation 57 Aggrastat ® tirofiban hydrochloride 57 somatostatin analogs 57 immune dysregulation 57 TGF β 57 narcolepsy cataplexy 57 MAGE A3 ASCI 57 hydroxy vitamin D 57 exocrine pancreas 57 hydroxyvitamin D levels 57 Thyroid hormones 57 microvascular dysfunction 57 podocyte 57 chronic prostatitis 57 SIRT1 gene 57 Shark cartilage 57 gene loci 57 osteoclast 57 cyclophilin D 57 brain neurochemistry 57 genetic susceptibilities 57 Onrigin 57 resveratrol supplementation 57 osteocalcin protein 57 radiolabeled TM# 57 FGFR2 57 protein conformation 57 postprandial glycemia 57 postoperative radiotherapy 57 lichen planus 57 atypical neuroleptics 57 bronchodilatory 57 hypothalamic pituitary 57 colorectal adenocarcinoma 57 antidiabetic therapy 57 alpha defensin 57 leaky gut 57 NPM1 mutation 57 SETDB1 57 HER2 amplification 57 intranasal corticosteroids 57 subclinical disease 57 Jhdm2a 57 cirrhotic liver 57 ERBB4 57 oestrogens 57 apoptosis induced 57 CAM modalities 57 neurodevelopmental outcomes 57 ON #.Na 57 idiopathic pulmonary 57 colorectal neoplasms 57 metabolic acidosis 57 prognostic variables 57 endogenous opioid 57 pharmacological approaches 57 echocardiographic parameters 57 ARF1 57 galiximab 57 multivitamin supplements 57 HLA G 57 activate AMPK 57 MetAP2 57 avosentan 57 B7 H3 57 primary hyperparathyroidism 57 Fas ligand 57 SIBO 57 MTHFR gene 57 STEP BD 57 interleukin 1beta 57 operable breast cancer 57 nonvascular 57 ORMDL3 57 K ras mutation 57 #q# deletion 57 ataluren 57 inherited predisposition 57 gp# vaccine 57 amyloid deposition 57 gene locus 57 plasma lipids 57 diabetic polyneuropathy 57 epigenetic markers 57 osteogenic differentiation 57 Nicotinamide 57 cyclin E 57 aetiology 57 soluble CD# ligand 57 relapsed ovarian cancer 57 bronchopulmonary dysplasia BPD 57 ivabradine 57 γ secretase 57 Vidofludimus 57 selective modulator 57 multivariable analysis 57 IDH mutations 57 dysfunction Zada 57 CINQUIL 57 radiochemotherapy 57 sphingolipid 57 Notch signaling 57 cisplatin chemotherapy 57 TGF b 57 APOE e4 57 salivary flow 57 Angiotensin converting enzyme 57 gemifloxacin 57 Ascherio 57 pharmacologic treatments 57 bacterial colonization 57 oestrogenic 57 troponins 57 organochlorine compounds 57 thalidomide Thalomid